Work

Global Manufacturing Experience with Idecabtagene Vicleucel in Patients with Relapsed and Refractory Multiple Myeloma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-194645

Authors: Surbhi Sidana, Christof Scheid, Peter J. Mueller, Petra Schuberth, Hardik Modi, Peter Krengel, Romain Piault, Xiaobo Zhong, Paula Rodríguez-Otero

Institutions: Stanford Medicine, Stanford University, University of Cologne, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), Clinica Universidad de Navarra, Universidad de Navarra

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405034680

Cites:

Cited by: 1

Related to: 10